Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment

Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment CDSCO is responsible for approval of drugs, conduct of clinical trials, laying down the standards for drugs, control over the quality of imported drugs in the country and coordination of the activities of state drug control organisations.

No comments:

Post a Comment